Westwood Holdings Group’s Haemonetics HAE Stock Holding History

Westwood Holdings Group’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,163,296	Closed	-$75.7M	–	407
2016 Q1	$75.7M	Buy	2,163,296 +31,067	+1%	+$1M	0.65%	59
2015 Q4	$68.7M	Buy	2,132,229 +284,761	+15%	+$9.24M	0.6%	63
2015 Q3	$59.7M	Sell	1,847,468 -230,316	-11%	-$8.67M	0.52%	75
2015 Q2	$85.9M	Sell	2,077,784 -203,295	-9%	-$8.57M	0.65%	61
2015 Q1	$102M	Buy	2,281,079 +383,190	+20%	+$16M	0.78%	37
2014 Q4	$71M	Buy	1,897,889 +564,441	+42%	+$20.7M	0.55%	74
2014 Q3	$46.6M	Sell	1,333,448 -14,960	-1%	-$534K	0.37%	102
2014 Q2	$47.6M	Buy	+1,348,408	New	+$45M	0.35%	104

Other funds holding HAE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Westwood Holdings Group's HAE Position: Q2 2016 in Review

Westwood Holdings Group sold out of Haemonetics (HAE) in Q2 2016, closing a stake of 2,163,296 shares — an estimated $75.7M sold.

Westwood Holdings Group first reported a position in HAE in Q2 2014 and held it in 8 quarters. The position peaked at $102M in Q1 2015. 177 funds tracked by Wall St. Rank hold HAE as of Q2 2016.

Westwood Holdings Group reported no remaining Haemonetics position as of Q2 2016 after selling out during the quarter.
Westwood Holdings Group sold 2,163,296 Haemonetics shares in Q2 2016, an estimated $75.7M.
Westwood Holdings Group first reported a position in Haemonetics in Q2 2014 and held it in 8 quarters.
Westwood Holdings Group's Haemonetics position peaked at $102M in Q1 2015.
177 funds tracked by Wall St. Rank held Haemonetics as of Q2 2016.

Based on Westwood Holdings Group's 13F filing for Q2 2016, filed 15 Aug 2016.